Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Fröhlich, E.
Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
Curr Pharm Des. 2020; 26(18):2137-2148
Doi: 10.2174/1381612826666200218094200
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Fröhlich Eleonore
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
In vitro screening for anti-cancer agents currently uses mainly cell lines in 2D culture. It is generally assumed that 3D culture, namely spheroids, represents physiologically more relevant models for tumors. Unfortunately, drug testing in spheroids is not as easy and reproducible as in 2D culture because there are factors that limit the universal use of spheroids as screening platforms. Technical problems in the generation of uniform spheroids, cell/tumor-specific differences in the ability to form spheroids, and more complex readout parameters are the main reasons for differences between spheroid data. The review discusses requirements for cancer spheroids to be representative models, suitable methodologies to generate spheroids for the screening and readout parameters for the evaluation of anti-cancer agents.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
- Find related publications in this database (Keywords)
-
Drug screening
-
cell culture
-
3D culture
-
cancer spheroids
-
anti-cancer drugs
-
2D culture